Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant TNFRSF8 anticorps

TNFRSF8 Reactivité: Humain FACS, IHC, IF, ELISA, InhA Hôte: Lapin Chimeric Ki-4 unconjugated Recombinant Antibody
N° du produit ABIN5668113
  • Antigène Voir toutes TNFRSF8 Anticorps
    TNFRSF8 (Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8))
    Type d'anticorp
    Recombinant Antibody
    Reactivité
    • 134
    • 31
    • 18
    • 16
    Humain
    Hôte
    • 86
    • 63
    • 14
    • 4
    • 1
    Lapin
    Clonalité
    • 96
    • 71
    • 1
    Chimeric
    Conjugué
    • 68
    • 14
    • 13
    • 12
    • 7
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Cet anticorp TNFRSF8 est non-conjugé
    Application
    • 101
    • 59
    • 59
    • 44
    • 36
    • 27
    • 26
    • 23
    • 13
    • 7
    • 6
    • 6
    • 6
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Flow Cytometry (FACS), Immunohistochemistry (IHC), Immunofluorescence (IF), ELISA, Inhibition Assay (InhA)
    Specificité
    The antibody binds to CD30.
    Attributs du produit

    OriginalSpeciesName: Mouse

    OriginalFormat: IgG1

    Purification
    Purified antibody.
    Immunogène
    Human CD30.
    Clone
    Ki-4
    Isotype
    IgG kappa
    Top Product
    Discover our top product TNFRSF8 Anticorps primaire
  • Indications d'application
    The antibody binds specifically to CD30, a cell membrane protein which belongs to the tumour necrosis factor receptor family. Incubation of CD30 positive L540 cells with Ki-4 antibody completely inhibits release of soluble CD30 (in contrast to Ki-3, Ab00474). CD30 is expressed on activated lymphocytes, and binding by its ligands TRAF2 and TRAF5 results in the activation of NF-kappaB, thereby regulating gene expression. CD30 is also associated with Hodgkin Lymphoma, and its expression acts as a tumour marker. Targeting the CD30 antigen with specific monoclonal antibodies is a possible therapy for Hodgkin's lymphoma.
    Commentaires

    This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques.

    Restrictions
    For Research Use only
  • Buffer
    PBS with 0.02 % Proclin 300.
    Agent conservateur
    ProClin
    Précaution d'utilisation
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C,-20 °C
    Stockage commentaire
    Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
  • Antigène
    TNFRSF8 (Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8))
    Autre désignation
    CD30 (TNFRSF8 Produits)
    Synonymes
    anticorps CD30, anticorps D1S166E, anticorps Ki-1, anticorps Cd30, anticorps Ki, anticorps TNFRSF8, anticorps TNF receptor superfamily member 8, anticorps tumor necrosis factor receptor superfamily, member 8, anticorps TNFRSF8, anticorps Tnfrsf8
    Sujet
    TNFRSF8, Tumor necrosis factor receptor superfamily member 8, CD30L receptor, Ki-1 antigen, Lymphocyte activation antigen CD30
    UniProt
    P28908
Vous êtes ici:
Support technique